REVIEW
Accepted on 06 Feb 2025
Research progress of T cells in cholangiocarcinoma
doi 10.3389/fimmu.2025.1453344
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Methods in Cancer Immunity and Immunotherapy: Volume II
Community Series in Methods in Cancer Immunity and Immunotherapy: Volume II
1,148
Total downloads
4,310
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 24 Jan 2025
Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors
doi 10.3389/fimmu.2025.1499074
- 293 views
STUDY PROTOCOL
Published on 09 Oct 2024
SHR-8068 combined with adebrelimab and bevacizumab in the treatment of refractory advanced colorectal cancer: study protocol for a single-arm, phase Ib/II study
doi 10.3389/fimmu.2024.1450533
- 969 views
CASE REPORT
Published on 16 Aug 2024
Etoposide, cisplatin, and sintilimab combined with anlotinib in successful treatment of adrenocortical carcinoma with lung metastasis: a case report
doi 10.3389/fonc.2024.1403762
- 650 views
- 1 citation
ORIGINAL RESEARCH
Published on 21 Mar 2024
PD-1 inhibitor combined with chemotherapy for first-line treatment of esophageal squamous cell carcinoma patients with distant metastasis: a real-world retrospective study
doi 10.3389/fimmu.2024.1353445
- 981 views
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted:
Impact
- 4,310Topic views
- 2,607Article views
- 1,148Article downloads